Berenberg Bank Reiterates Buy Rating for Advanced Medical Solutions Group (LON:AMS)

Advanced Medical Solutions Group (LON:AMS – Get Rating)‘s stock had its “buy” rating reaffirmed by analysts at Berenberg Bank in a note issued to investors on Wednesday, MarketBeat Ratings reports. They currently have a GBX 310 ($3.78) price target on the stock. Berenberg Bank’s price target suggests a potential upside of 29.17% from the company’s previous close.

Advanced Medical Solutions Group Stock Performance

AMS stock opened at GBX 240 ($2.93) on Wednesday. The company has a quick ratio of 4.58, a current ratio of 5.65 and a debt-to-equity ratio of 4.28. The firm has a 50 day moving average of GBX 258.11 and a two-hundred day moving average of GBX 262.40. The company has a market capitalization of £520.58 million, a price-to-earnings ratio of 3,012.50, a P/E/G ratio of 2.77 and a beta of 0.60. Advanced Medical Solutions Group has a 12 month low of GBX 229 ($2.79) and a 12 month high of GBX 319.50 ($3.89).

About Advanced Medical Solutions Group

(Get Rating)

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, France, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.